Status:
COMPLETED
Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders
Lead Sponsor:
Pacific Health Foundation
Collaborating Sponsors:
Bristol-Myers Squibb
Conditions:
Hepatitis B
Eligibility:
All Genders
18+ years
Brief Summary
We propose a largely retrospective study with short-term prospective follow-up in a subgroup of patients who have not yet been treated with 48 weeks of entecavir following partial response to adefovir...
Detailed Description
Amendment was made, and approved by WIRB in January 2009, to this protocol: We propose a largely retrospective study with short-term prospective follow-up in a subgroup of patients who have not yet be...
Eligibility Criteria
Inclusion
- KEY INCLUSION CRITERIA:
- Age 18 years or older
- All genders and ethnicity
- Positive HBsAg
- HBeAg positive and negative
- Pretreatment HBV DNA of 10,000 copies/mL or higher (for purposes of this study, both copies and equivalent IU measurements will be recorded and analyzed)
- Patients who are switched to, or prescribed, entecavir after treatment with adefovir for at least 12 weeks by the providing physician.
- Patients with and without prior lamivudine exposure will be enrolled but enrollment of lamivudine experienced cases will be limited to no more than 30 patients total
- KEY EXCLUSION CRITERIA:
- Patients who refused to consent to the study
- Patients younger than 18
- Vulnerable subjects such as pregnant women, prisoners, employees, patients with significant cognitive deficits.
- Patients with prior exposure to another nucleoside for more than 2 weeks. Those with prior exposure to lamivudine will be enrolled under conditions detailed above.
- HIV co-infection
- HCV co-infection
- HDV co-infection
- Recipients of solid organ transplantation
- Patients who receive high-dose steroid (60 mg/d or higher and for longer than 10 days)
Exclusion
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00704106
Start Date
May 1 2008
End Date
October 1 2011
Last Update
November 14 2022
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University Medical Center
Palo Alto, California, United States, 94304
2
San Jose Gastroenterology
San Jose, California, United States, 95116
3
San Jose Gastroenterology
San Jose, California, United States, 95128
4
Asian Village Medical Clinic
Chicago, Illinois, United States, 60640